Insights

Innovative Therapeutics Focus Sova Pharmaceuticals specializes in developing novel treatments for pain and inflammation by targeting gasotransmitter modulation, indicating potential opportunities to collaborate on cutting-edge therapies and secure interest from research-focused healthcare providers.

Niche Market Position With a focus on unmet medical needs and emerging enzymatic targets like cystathionine-γ-lyase, Sova presents an attractive partner for companies seeking to expand their portfolio in innovative pain and inflammation therapeutics.

Growth Potential Although currently smaller with a revenue between 1M and 10M, Sova's dedication to breakthrough science suggests opportunities for strategic partnerships, research alliances, and co-development deals to accelerate their market reach.

Technology Stack Insights Utilizing analytics tools like Baidu Analytics and Histats indicates an active approach to digital engagement and data-driven research, which can be leveraged for targeted outreach and collaborative marketing strategies.

Market Trends Alignment The company's focus on innovative pain and inflammation therapies aligns with broader trends toward personalized medicine and novel drug development, creating potential sales opportunities with biotech firms, contract research organizations, and healthcare companies investing in this space.

Sova Pharmaceuticals, Inc. Email Formats	Example	Percentage
FLast@sovapharma.com	JDoe@sovapharma.com	50%
FLast@sovapharma.com	JDoe@sovapharma.com	50%

Sova Pharmaceuticals, Inc. Email Formats

Example

Percentage

FLast@sovapharma.com

JDoe@sovapharma.com

50%

FLast@sovapharma.com

JDoe@sovapharma.com

50%

Frequently Asked Questions

Where is Sova Pharmaceuticals, Inc.'s headquarters located?

Sova Pharmaceuticals, Inc.'s main headquarters is located at 11099 North Torrey Pines Road, Suite 290. The company has employees across 1 continents, including North America.

What is Sova Pharmaceuticals, Inc.'s phone number?

You can contact Sova Pharmaceuticals, Inc.'s main corporate office by phone at

+1-858-750-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sova Pharmaceuticals, Inc.'s official website and social media links?

Sova Pharmaceuticals, Inc.'s official website is sovapharma.com and has social profiles on LinkedIn.

What is Sova Pharmaceuticals, Inc.'s SIC code NAICS code?

Sova Pharmaceuticals, Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sova Pharmaceuticals, Inc. have currently?

As of December 2025, Sova Pharmaceuticals, Inc. has approximately 5 employees across 1 continents, including North America. Key team members include Vice President: M. N.Administrative Assistant: K. P.. Explore Sova Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Sova Pharmaceuticals, Inc. belong to?

Sova Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Sova Pharmaceuticals, Inc. use?

Sova Pharmaceuticals, Inc.'s tech stack includes HistatsBaidu AnalyticsApacheNginx.

What is Sova Pharmaceuticals, Inc.'s email format?

Sova Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@sovapharma.com. Find more Sova Pharmaceuticals, Inc. email formats with LeadIQ.

When was Sova Pharmaceuticals, Inc. founded?

Sova Pharmaceuticals, Inc. was founded in 2010.

Sova Pharmaceuticals, Inc.

Q: How many employees does Sova Pharmaceuticals, Inc. have currently?

Sova Pharmaceuticals, Inc. has approximately 5 employees.

Q: What technology does Sova Pharmaceuticals, Inc. use?

Sova Pharmaceuticals, Inc.'s tech stack includes Histats, Apache, Nginx, Baidu Analytics.

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

Sova Pharmaceuticals Inc. is a privately-held biopharmaceutical company founded in 2010. The company is engaged in the discovery and development of innovative therapeutics for the treatment of pain and inflammation. These areas represent large areas of unmet medical need as few new molecular targets are being pursued as candidates for the treatment of both pain and inflammation, and even fewer new drugs active against such targets have been commercialized that will benefit patients. There is increasing recognition that increased local concentrations of the gasotransmitter, hydrogen sulfide, are contributory to certain disease states characterized by pain and inflammation. Sova is dedicated to modulation of cystathionine-γ-lyase (CSE), a novel enzymatic target involved in the production of hydrogen sulfide.

Insights

Similar companies to Sova Pharmaceuticals, Inc.

Aurobindo Pharma Limited

Glenmark Pharmaceuticals

Wockhardt Ltd.

Cipla

Dr. Reddy's Laboratories

Intas Biopharmaceuticals Ltd.

Hikma Pharmaceuticals